Shivom Roadmap, Release Strategy & Status Update for 2019 The march of time is relentless and as we start the second quarter of 2019, now is a good time to share some latest updates on Shivom’s roadmap, our evolving blockchain-based genomics & bio datahub and secure-storage and sharing platform, new partnerships and other developments pertaining to the Shivom ecosystem…

Living DNA’s 3-in-1 ancestry kit will provide Shivom’s customers with the ability to trace their origins back via maternal ancestors, and see how they moved around the world over thousands of years. London, United Kingdom — April 15, 2019 — Shivom, a biotechnology data and analysis company optimising the way…

Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, and Family Care Path (FCPI), a spin-off company from Cleveland Clinic adapting and marketing web-based clinical decision support applications, are collaborating to integrate FCPI’s MyLegacy application within Shivom’s marketplace…

Shivom — a data discovery and analysis solutions platform — on Tuesday unveiled its second release — Alpha 2.O. Leveraging the latest advancements in blockchain and machine-learning technology, Shivom is optimising how DNA is shared, secured and analysed in order to bring exponential value to the genomics industry. In November…

How often have you come across a patient of cervical cancer around you? Chances are, rarely. But reality begs to differ. According to the World Health Organisation (WHO), over six per cent women around the world (including 570,000 new cases) suffered from cervical cancer in 2018. Sadly, the statistics of…

End of Year Roundup As 2018 draws to a close, the team at Shivom are incredibly proud of what we’ve accomplished in the past year, and look forward to progressing in our mission to build the world’s largest blockchain-based genomic data hub for years to come. As those who have…

Back in August, we announced that we would be releasing a platform in order for our community to test and give us feedback on the first iteration of our Alpha product. After onboarding a wealth of new talent and welcoming Henry Ines to the role of CEO, we felt it…

We develop our blockchain-based platform to target precision medicine. As we enter the home stretch of 2018, Project Shivom celebrates an historic and successful ICO, expansion of our token exchange across four cryptocurrency platforms, and a restructured company leadership now helmed by CEO Henry Ines. Next, we look forward to…

We know the ability to collect and analyze a person’s DNA to identify and potentially treat inherited medical conditions is a relatively recent phenomenon in the spectrum of medical history. While genomic science and research (which represents the more complex interaction of genes and the environment vs. study of particular…